Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-20-076538
Filing Date
2020-06-25
Accepted
2020-06-24 18:59:03
Documents
1
Period of Report
2020-06-24

Document Format Files

Seq Description Document Type Size
1 6-K tm2023372d1_6k.htm 6-K 12269
  Complete submission text file 0001104659-20-076538.txt   13280
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38512 | Film No.: 20986703
SIC: 2834 Pharmaceutical Preparations